Target intelligence / Profile preview

PRDM6 antisense RNA 1 (PRDM6-AS1)

Target
PRDM6-AS1
Molecular classification
Other (antisense long non-coding RNA, if existence is confirmed)
01

Overview

PRDM6 antisense RNA 1 (PRDM6-AS1) may denote an antisense long non-coding RNA transcript related to the PRDM6 gene. However, current literature and molecular databases focus on PRDM6, a histone methyltransferase and transcription factor involved in vascular differentiation, cell cycle regulation, apoptosis, and oncogenesis[1][2][4]. There is no substantial published characterization or evidence supporting PRDM6-AS1 as a therapeutically relevant molecule or biologically active transcript. Its existence is likely speculative, unvalidated, or incorrectly listed as a molecular target. Key distinctions: - PRDM6 (the sense gene/protein) is classified as a histone methyltransferase, transcription factor, and epigenetic regulator[1][2][4]. - PRDM6-AS1 is not an established molecular entity in existing scientific sources; the entry appears to be incorrect or unsubstantiated as a target[1][2][4]. - If you meant the sense gene PRDM6, detailed functional and disease role information can be provided; if you meant the antisense RNA, more evidence is needed for meaningful annotation. If more detailed information about genuine PRDM6 antisense transcripts emerges, structured entries should be updated to reflect validated biological roles.

Other names
PRDM6-AS1PRDM6 antisense RNA 1

Beyond the preview

Go deeper on PRDM6 antisense RNA 1 (PRDM6-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRDM6 antisense RNA 1 (PRDM6-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call